Kainova Therapeutics

Montreal, Canada · Founded 2001 · Privately Held (backing)

Developer of medical therapeutics designed for the treatment of central nervous system (CNS) diseases and cancer. Kainova Therapeutics is based in Montreal, Canada and was founded in 2001. Its last reported valuation was $92 million in May 2022. It has raised $114 million.

Last reported valuation
$92.0M
Oct 2026
Priced at
—
Total raised
$113.9M
Last round
—

Who backs Kainova Therapeutics?

14 investors
InvestorType
Investissement QuebecOther
Omnes CapitalPE / buyout
Turenne GroupePE / buyout
Schroders CapitalOther
Viva BioInnovatorOther
3B Future Health Fund—
50 North Ventures—
Alsace Creation—
CTI Life Sciences Fund—
Michael J. Fox Foundation—
+ 4 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Kainova Therapeutics investors

14 investors are on record for Kainova Therapeutics, including Investissement Quebec, Omnes Capital, Turenne Groupe and Schroders Capital.

Free account
More of Kainova Therapeutics with a free account
  • ·The complete investor list: 14 names
  • ·Watch Kainova Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 14 firms already write checks for companies like Kainova Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View